|1.||Cuzick, Jack: 39 articles (06/2015 - 01/2003)|
|2.||Dowsett, Mitch: 37 articles (06/2015 - 02/2002)|
|3.||Howell, Anthony: 33 articles (06/2015 - 04/2002)|
|4.||Buzdar, Aman U: 25 articles (07/2015 - 06/2002)|
|5.||Sestak, Ivana: 16 articles (06/2015 - 09/2008)|
|6.||Buzdar, Aman: 16 articles (06/2015 - 06/2002)|
|7.||Ingle, James N: 14 articles (07/2015 - 08/2002)|
|8.||Gnant, Michael: 14 articles (03/2015 - 08/2005)|
|9.||Dixon, J Michael: 14 articles (01/2013 - 06/2002)|
|10.||Jakesz, Raimund: 13 articles (01/2013 - 05/2003)|
|1.||Breast Neoplasms (Breast Cancer)
12/01/2007 - "Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer."
03/01/2013 - "[Three patients with local recurrence of ER-positive breast cancer for whom anastrozole was clinically effective]."
03/01/1996 - "Anastrozole is an effective and well tolerated treatment for postmenopausal patients with advanced breast cancer. "
10/01/2008 - "Anastrozole therapy is a useful treatment for postmenopausal woman with ER-positive recurrent breast cancer."
09/01/2002 - "Anastrozole therapy is a useful treatment for postmenopausal women with ER positive advanced breast cancer."
08/01/2008 - "Anastrozole was effective for the control of tumor growth and her symptoms. "
07/01/2011 - "In this study we set out to investigate the significance of intrinsic subtypes within a group of ER+ve breast cancers treated with neoadjuvant anastrozole. "
12/01/2003 - "Phase II trial of anastrozole in women with asymptomatic müllerian cancer."
11/15/2015 - "Formulation and evaluation of anastrozole, an anti-cancer drug loaded in different biodegradable polymeric nanoparticles. "
01/01/2015 - "This likely explains tumor progression on Anastrozole. "
|3.||Neoplasm Metastasis (Metastasis)
01/01/2014 - "She had been started on anastrozole in May 2013 for bony metastases, detected on a bone scan. "
08/06/2013 - "Normal weight patients with additional 3 years of anastrozole halved their risk of disease recurrence (disease-free survival (DFS) HR 0.48; P=0.02) and death (HR 0.45; P=0.06) and had only a fifth of the risk of distant metastases (HR 0.22; P=0.05) compared with normal weight patients without any further treatment. "
08/01/2006 - "Uterine metastases should be kept in mind in asymptomatic patients on anastrozole therapy."
12/01/2003 - "The results reveal anastrozole to be an effective and valuable first- and second-line therapy in postmenopausal women with ABC and visceral metastases, showing similar CB to other endocrine therapies."
12/01/2003 - "In patients with or without visceral metastases, second-line treatment with anastrozole resulted in a CB rate of 31.4 and 51.8%, respectively, compared with 31.9 and 47.1%, respectively, for those treated with MA. "
06/01/2010 - "After the optimal time for SLW to inhibit invasion ability of endometrial cells was identified based on time-effect relationship, another endometrial cells were divided into six groups: hysteromyoma endometrium group, eutopic endometrium of endometriosis group, eutopic endometrium of endometriosis + middle dose of SLW serum group, eutopic endometrium of endometriosis + middle dose of SLW serum + E2 group, eutopic endometrium of endometriosis + anastrozole serum group , and eutopic endometrium of endometriosis + E2 group. "
03/01/2010 - "After the optimal time for SLW to induce apoptosis of eutopic endometrial cells of endometriosis in early stage and late stage was identified based on time-effect relationship, another endometrium cells were divided into six groups: hysteromyoma endometrium group, eutopic endometrium of endometriosis group, eutopic endometrium of endometriosis + middle dose of SLW serum group, eutopic endometrium of endometriosis + anastrozole serum group, eutopic endometria of endometriosis + middle dose of SLW serum + E2 group and eutopic endometrium of endometriosis + E2 group. "
05/01/2015 - "Aromatase inhibitor (anastrozole) may be an effective treatment for endometriosis due to inhibition of cellular aromatase."
08/01/2005 - "Anastrazole and oral contraceptives: a novel treatment for endometriosis."
01/01/2004 - "In a prospective randomized trial, we evaluated the efficacy of using either a combination of anastrozole and goserelin for 6 months or goserelin alone for 6 months after conservative surgery for severe endometriosis. "
01/01/2013 - "The aim was to investigate the impact of the genetic polymorphisms, CYP19A1, 17-β-HSD-1 and FTO, on the response to anastrozole in metastatic breast carcinoma (MBC) and to evaluate the impact of those polymorphisms on various clinicopathologic features. "
07/01/2009 - "To our knowledge, this is the second case of lobular breast carcinoma metastasized to the uterus under anastrozole therapy. "
01/01/2007 - "Thereafter she continued adjuvant treatment for breast carcinoma with anastrazole. "
08/01/2006 - "This is the first report of breast carcinoma metastatic to the endometrium in a patient on adjuvant anastrozole therapy. "
01/01/2013 - "Cyberknife radiotherapy and anastrozole for the treatment of advanced progressive low-grade papillary serous ovarian carcinoma: A case report."
|1.||Drug Therapy (Chemotherapy)
|4.||Segmental Mastectomy (Lumpectomy)